Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension

Although angiotensin receptor blockers have different receptor binding properties no comparative studies with cardiovascular disease (CVD) end points have been performed within this class of drugs. The aim of this study was to test the hypothesis that there are blood pressure independent CVD-risk di...

Descripción completa

Detalles Bibliográficos
Autores principales: Kjeldsen, S E, Stålhammar, J, Hasvold, P, Bodegard, J, Olsson, U, Russell, D
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834374/
https://www.ncbi.nlm.nih.gov/pubmed/19890371
http://dx.doi.org/10.1038/jhh.2009.77

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834374/
https://www.ncbi.nlm.nih.gov/pubmed/19890371
http://dx.doi.org/10.1038/jhh.2009.77

Ejemplares similares